Literature DB >> 18286468

Gene expression profiling of macrophages following mice treatment with an immunomodulator medication.

Carolina Camargo de Oliveira1, Simone Martins de Oliveira, Viviane M Goes, Christian M Probst, Marco Aurelio Krieger, Dorly de Freitas Buchi.   

Abstract

Canova (CA) is a complex homeopathic medication used in diseases where the immune system is depressed. Previous studies demonstrated that it is neither toxic nor mutagenic and activates macrophages. We now evaluate CA effects on cytokine production and gene expression from mice macrophages. The global view of changes in expression of genes with known functions can provide a vivid picture of the way in which cell adapts to a changing environment or a challenge. We found a decrease in IL-2 and IL-4 production and a differential expression in 147 genes from CA group. These genes are mainly involved in transcription/translation, cell structure and dynamics, immune response, cytoprotection, enzymatic process, and receptors/ligands. With gene expression analysis we state that this medication provokes a reaction that involves alterations in gene expression profile mainly in the ones involved with macrophages activation, corroborating the laboratorial research and the clinical data. 2008 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18286468     DOI: 10.1002/jcb.21713

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  11 in total

1.  Testing the nanoparticle-allostatic cross-adaptation-sensitization model for homeopathic remedy effects.

Authors:  Iris R Bell; Mary Koithan; Audrey J Brooks
Journal:  Homeopathy       Date:  2013-01       Impact factor: 1.444

2.  Analytical workflow profiling gene expression in murine macrophages.

Authors:  Scott E Nixon; Dianelys González-Peña; Marcus A Lawson; Robert H McCusker; Alvaro G Hernandez; Jason C O'Connor; Robert Dantzer; Keith W Kelley; Sandra L Rodriguez-Zas
Journal:  J Bioinform Comput Biol       Date:  2015-01-14       Impact factor: 1.122

3.  In vitro and in vivo anticancer properties of a Calcarea carbonica derivative complex (M8) treatment in a murine melanoma model.

Authors:  Fernando S F Guimarães; Lucas F Andrade; Sharon T Martins; Ana P R Abud; Reginaldo V Sene; Carla Wanderer; Inés Tiscornia; Mariela Bollati-Fogolín; Dorly F Buchi; Edvaldo S Trindade
Journal:  BMC Cancer       Date:  2010-03-25       Impact factor: 4.430

Review 4.  Integrative nanomedicine: treating cancer with nanoscale natural products.

Authors:  Iris R Bell; Barbara Sarter; Mary Koithan; Prasanta Banerji; Pratip Banerji; Shamini Jain; John Ives
Journal:  Glob Adv Health Med       Date:  2014-01

5.  Transcriptome Profiling of Wheat Seedlings following Treatment with Ultrahigh Diluted Arsenic Trioxide.

Authors:  Ilaria Marotti; Lucietta Betti; Valeria Bregola; Sara Bosi; Grazia Trebbi; Giovanni Borghini; Daniele Nani; Giovanni Dinelli
Journal:  Evid Based Complement Alternat Med       Date:  2014-11-27       Impact factor: 2.629

6.  Effects of Extreme Dilutions of Apis mellifica Preparations on Gene Expression Profiles of Human Cells.

Authors:  Elisabetta Bigagli; Cristina Luceri; Andrea Dei; Simonetta Bernardini; Piero Dolara
Journal:  Dose Response       Date:  2016-01-06       Impact factor: 2.658

7.  Stimulation of lymphocyte anti-melanoma activity by co-cultured macrophages activated by complex homeopathic medication.

Authors:  Fernando S F Guimarães; Ana P R Abud; Simone M Oliveira; Carolina C Oliveira; Beatriz César; Lucas F Andrade; Lucélia Donatti; Juarez Gabardo; Edvaldo S Trindade; Dorly F Buchi
Journal:  BMC Cancer       Date:  2009-08-22       Impact factor: 4.430

8.  A model for homeopathic remedy effects: low dose nanoparticles, allostatic cross-adaptation, and time-dependent sensitization in a complex adaptive system.

Authors:  Iris R Bell; Mary Koithan
Journal:  BMC Complement Altern Med       Date:  2012-10-22       Impact factor: 3.659

9.  Treatment with at homeopathic complex medication modulates mononuclear bone marrow cell differentiation.

Authors:  Beatriz Cesar; Ana Paula R Abud; Carolina C de Oliveira; Francolino Cardoso; Raffaello Popa Di Bernardi; Fernando S F Guimarães; Juarez Gabardo; Dorly de Freitas Buchi
Journal:  Evid Based Complement Alternat Med       Date:  2011-02-17       Impact factor: 2.629

10.  Modulation of Signal Proteins: A Plausible Mechanism to Explain How a Potentized Drug Secale Cor 30C Diluted beyond Avogadro's Limit Combats Skin Papilloma in Mice.

Authors:  Anisur Rahman Khuda-Bukhsh; Soumya Sundar Bhattacharyya; Saili Paul; Suman Dutta; Naoual Boujedaini; Philippe Belon
Journal:  Evid Based Complement Alternat Med       Date:  2011-06-18       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.